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Background:  Patients with left ventricular (LV) dysfunction likely to benefit from revascularization may be better selected using F-18-
fluorodeoxyglucose positron emission tomography (FDG PET) imaging. We studied whether FDG PET directed management improves Quality of Life (QoL).
Methods:  Among 430 patients with LV dysfunction (EF=<35%) randomized in the PARR2 trial to FDG PET guided management vs standard care, 
QoL scores using EQ5D were obtained in 391 patients (FDG PET 195; standard 196) at 0-12 months (m). EQ5D scores between FDG PET and 
standard arms were compared using Mixed Model Repeated Measures (MMRM). Subgroup analysis compared EQ5D scores between patients in 
the FDG PET arm who adhered to PET recommendations (ADHERE) vs standard using MMRM. Interaction of revascularization with management was 
assessed using a general linear model.
Results:  A trend towards higher EQ5D scores in the FDG PET arm was observed (p=0.06). Subgroup analysis showed a significant difference 
favoring FDG PET adherence (p=0.04). Higher QoL at 6 m for FDG PET (p=0.02) and ADHERE (p=0.02) compared to standard were observed. For 
revascularization, interaction with management allocation (FDG PET vs standard) for QoL was observed (6 m p=0.01; 12 m p=0.1); and for ADHERE 
(6 m p=0.01; 12 m p=0.1).
Conclusion: FDG PET directed management improves QoL, at least in the short term and when there is adherence to recommendations. This may 
be related to revascularization, suggesting better selection for treatment using FDG PET. 
